Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06378684
Status:
COMPLETED
Last Update Posted:
2024-04-22
First Post:
2024-03-29
Brief Title:
To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers
Sponsor:
JW Pharmaceutical
Organization:
JW Pharmaceutical
Study Overview
Official Title:
A Randomized Open-label Multiple-dose 63 Crossover Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of JW0104 and C2207 in Healthy Adults
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective is to evaluate the safety and Pharmacokinetic Interactions after adminitration drugTreatment A or B or AB in Healthy Volunteers
Detailed Description:
Pharmacokinetic Interactions Describes the blood concentration statistically by pharmacokinetic blood collection time and treatment group
Safety All adverse events are summarized in terms of the number of subjects expression rate and number of expressions of adverse reactions by treatment group
Safety All adverse events are summarized in terms of the number of subjects expression rate and number of expressions of adverse reactions by treatment group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None